These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21787158)

  • 61. Effect of coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain-injury model in rats.
    Kalayci M; Unal MM; Gul S; Acikgoz S; Kandemir N; Hanci V; Edebali N; Acikgoz B
    BMC Neurosci; 2011 Jul; 12():75. PubMed ID: 21801363
    [TBL] [Abstract][Full Text] [Related]  

  • 62. THE ROLE OF OXIDATIVE STRESS IN PATIENTS WITH CHRONIC KIDNEY DISEASE.
    Al-Badry SH; Ibrahim NG; AlMashhadani HA; Kadhim MM
    Wiad Lek; 2023; 76(5 pt 1):951-955. PubMed ID: 37326075
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The evaluation of oxidative stress in patients with chronic renal failure.
    Erdoğan C; Unlüçerçi Y; Türkmen A; Kuru A; Cetin O; Bekpinar S
    Clin Chim Acta; 2002 Aug; 322(1-2):157-61. PubMed ID: 12104095
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hormonal influence on coenzyme Q(10) levels in blood plasma.
    Mancini A; Festa R; Raimondo S; Pontecorvi A; Littarru GP
    Int J Mol Sci; 2011; 12(12):9216-25. PubMed ID: 22272129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MYELOPEROXIDASE AND COENZYME Q10 MODULATED IN THE CHRONIC KIDNEY DISEASE PATIENTS.
    Aziz H; Hussein A; Zakari M
    Georgian Med News; 2023 Nov; (344):124-128. PubMed ID: 38236112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biomonitoring of Oxidative-Stress-Related Genotoxic Damage in Patients with End-Stage Renal Disease.
    Yüzbaşıoğlu Y; Hazar M; Aydın Dilsiz S; Yücel C; Bulut M; Cetinkaya S; Erdem O; Basaran N
    Toxics; 2024 Jan; 12(1):. PubMed ID: 38251024
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adverse hematological profiles associated with chlorpromazine antipsychotic treatment in male rats: Preventive and reversal mechanisms of taurine and coenzyme-Q10.
    Obukohwo OM; Ben-Azu B; Nwangwa EK; Ohwin EP; Igweh JC; Adeogun Adetomiwa E
    Toxicol Rep; 2024 Jun; 12():448-462. PubMed ID: 38693965
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coenzyme Q10 supplementation may improve diastolic heart functions especially coronary artery disease patients.
    Balta S; Demırkol S; Celik T
    Hemodial Int; 2013 Jul; 17(3):467-8. PubMed ID: 23527797
    [No Abstract]   [Full Text] [Related]  

  • 69. Coenzyme Q10 supplementation and diastolic heart functions in hemodialysis patients: a randomized double-blind placebo-controlled trial.
    Turk S; Baki A; Solak Y; Kayrak M; Atalay H; Gaipov A; Aribas A; Akilli H; Biyik Z; Okudan N; Gokbel H
    Hemodial Int; 2013 Jul; 17(3):374-81. PubMed ID: 23360359
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal mitochondrial cytopathies.
    Emma F; Montini G; Salviati L; Dionisi-Vici C
    Int J Nephrol; 2011; 2011():609213. PubMed ID: 21811680
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of coenzyme Q10 in patients with chronic kidney disease: protocol for a systematic review.
    Xu Y; Liu J; Han E; Wang Y; Gao J
    BMJ Open; 2019 May; 9(5):e029053. PubMed ID: 31092669
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical Trial of the Effects of Coenzyme Q10 Supplementation on Biomarkers of Inflammation and Oxidative Stress in Diabetic Hemodialysis Patients.
    Fallah M; Askari G; Soleimani A; Feizi A; Asemi Z
    Int J Prev Med; 2019; 10():12. PubMed ID: 30774846
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients.
    Dozio E; Ambrogi F; de Cal M; Vianello E; Ronco C; Corsi Romanelli MM
    Mediators Inflamm; 2018; 2018():1347432. PubMed ID: 30410419
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients.
    Fallah M; Askari G; Soleimani A; Feizi A; Asemi Z
    Int Urol Nephrol; 2018 Nov; 50(11):2073-2079. PubMed ID: 30251010
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of coenzyme Q10 supplementation on C-reactive protein and homocysteine as the inflammatory markers in hemodialysis patients; a randomized clinical trial.
    Zahed NS; Ghassami M; Nikbakht H
    J Nephropathol; 2016 Jan; 5(1):38-43. PubMed ID: 27047809
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A review on the role of quinones in renal disorders.
    Madeo J; Zubair A; Marianne F
    Springerplus; 2013 Dec; 2(1):139. PubMed ID: 23577302
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coenzyme Q10 and its relation with oxidant and antioxidant system markers in patients with end-stage renal disease.
    Gokbel H; Atalay H; Okudan N; Solak Y; Belviranli M; Turk S
    Ren Fail; 2011; 33(7):677-81. PubMed ID: 21787158
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis.
    Bibi G; Green Y; Nagler RM
    Ther Apher Dial; 2008 Apr; 12(2):164-70. PubMed ID: 18387167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
    Pawlak K; Pawlak D; Mysliwiec M
    Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis.
    Demirci S; Sekeroğlu MR; Noyan T; Köçeroğlu R; Soyoral YU; Dülger H; Erkoç R
    Cell Biochem Funct; 2011 Apr; 29(3):249-54. PubMed ID: 21465497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.